JENNIFER WADDLE: Open Payments
NPI 1366656787 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 24 payments from 12 companies in 2025. Trend: 2023 $686 · 2024 $378 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $111 |
| Organon LLC | 3 | $61 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $46 |
| Sage Therapeutics, LLC | 2 | $46 |
| SHIELD THERAPEUTICS INC | 2 | $41 |
| MILLICENT US INC | 2 | $29 |
| Dexcom, Inc. | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Smith+Nephew, Inc. | 1 | $19 |
Products named: Veozah, NEXPLANON, ZURZUVAE, ACCRUFER, FEMLYV, Dexcom G6 Transmitter, Qelbree, Mirena.
Industry payments across LA — which companies pay providers there.
